CROs Are Leading The Charge In New Clinical Trial Technology
By Jim Reilly
The findings from the Veeva 2019 Unified Clinical Operations Survey: Annual CRO Report confirmed that contract research organizations (CROs) are continuing to lead the industry in improving clinical trial performance. CROs are increasingly adopting purpose-built technologies to eliminate manual processes, modernize key areas of clinical trials, bolster collaboration and, ultimately, improve the quality and speed of trials.
But what else does the survey reveal about how clinical trials are evolving and the role that CROs are playing in driving the industry forward? Here, I answer some of the most common questions I’ve received about this year’s report.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.